Mode
Text Size
Log in / Sign up
N/A N=351 Randomized Treatment

Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis

Osteoarthritis

Enrolled (actual)
351
Serious AEs
1.4%
Results posted
Jan 2014
Primary outcome: Primary: WOMAC Functional Status - Difference From Baseline — 20.9; 18.5 Score — p=0.26

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Arthroscopic partial menisectomy (Procedure); Standard physical therapy (Other); Postoperative rehabilitative physical therapy (Other)
Age
Adult, Older Adult · 45+ yrs
Sex
All
Sponsor
Brigham and Women's Hospital
Primary completion
Feb 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
WOMAC Functional Status - Difference From Baseline
20.9; 18.5 0.26
SECONDARY
KOOS Pain - Difference From Baseline
24.2; 21.3 0.16
SECONDARY
SF-36 Physical Functional Status Scale - Difference From Baseline
24.2; 23.1 0.68
SECONDARY
Total Knee Replacement - Subjects Received
16; 9
SECONDARY
KOOS Pain - Mean at 60 Months
18.2; 19.4

Summary

There are two cartilage structures, called menisci, in each knee joint. A torn meniscus can be caused by a traumatic injury or aging-related degeneration. Osteoarthritis (OA) is a type of arthritis that is caused by the breakdown and eventual loss of another type of cartilage that covers the end of bones within a joint. In people who have knee OA, a meniscal tear can easily lead to disability. This study will compare the effectiveness of two recommended treatments, surgery and physical therapy, for people with a torn meniscus and knee OA.

Eligibility Criteria

Inclusion Criteria

  • OA symptoms lasting at least 1 month and managed with medications, activity limitations, and/or physical therapy
  • At least one symptom consistent with a torn meniscus. Symptoms may include clicking, catching, popping, giving way, pain with pivot or torque, episodic pain, and/or pain that is acute and localized to one joint line.
  • Available knee X-ray (within 6 months) and MRI (within 3 years)
  • Evidence of osteophyte formation or cartilage fissure, tear, or loss on a knee MRI OR plain radiographic evidence of osteophyte formation or joint space narrowing
  • Evidence of a meniscal tear (tear extending to surface of meniscus) on a knee MRI
  • Willingness to undergo random assignment and sign an informed consent

Exclusion Criteria

  • Chronically locked knee
  • Kellgren-Lawrence Grade IV status, indicating advanced OA and usually the need for total knee replacement
  • Contraindication to MRI
  • Radiographic chondrocalcinosis (a condition in which there are deposits of calcium pyrophosphate dihydrate [CPPD] crystals in one or more joints that eventually result in damage to the affected joints) AND acute symptomatic pseudogout
  • Inflammatory diseases (e.g., rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, gout, pseudogout)
  • Injection with viscosupplementation in the affected knee in the 4 weeks before study entry
  • Any medical contraindications to surgery or physical therapy
  • Both knees are symptomatic for meniscal tears and a candidate for bilateral APMs
  • Prior surgery on an affected knee
  • Pregnancy or possible pregnancy
  • Claim filed for worker's compensation
  • Unable or unwilling to give informed consent
  • Unable or unwilling to attend physical therapy sessions at designated locations or in the community
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00597012). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search